• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地高辛和奎尼丁对犬心房颤动阈值的独立及交互作用

Independent and interactive effects of digoxin and quinidine on the atrial fibrillation threshold in dogs.

作者信息

Gold R L, Bren G B, Katz R J, Varghese P J, Ross A M

出版信息

J Am Coll Cardiol. 1985 Jul;6(1):119-23. doi: 10.1016/s0735-1097(85)80262-x.

DOI:10.1016/s0735-1097(85)80262-x
PMID:4008768
Abstract

To assess the effects of digoxin as single therapy and in combination with quinidine in the treatment of atrial fibrillation, the atrial fibrillation threshold was determined from the right atrial appendage and Bachmann's bundle in 11 open chest dogs. In group 1 (six dogs), the atrial fibrillation threshold was determined at baseline, post-quinidine (10 mg/kg intravenously) and then post-digoxin (50 micrograms/kg intravenously). In group 2 (five dogs), the order of drug administration was reversed. The results of this study were: 1) Digoxin had no significant effect on the atrial fibrillation threshold when given alone. 2) Quinidine significantly increased the atrial fibrillation threshold (p less than 0.002) and the addition of digoxin resulted in a further increase in threshold (p less than 0.002). 3) Quinidine produced greater suppression of atrial fibrillation induction at the right atrial site than at the Bachmann's bundle site, suggesting differential effects of quinidine on atrial fibers.

摘要

为评估地高辛单一疗法以及与奎尼丁联合使用在治疗心房颤动中的效果,在11只开胸犬身上从右心耳和巴赫曼束测定心房颤动阈值。在第1组(6只犬)中,在基线、静脉注射奎尼丁(10毫克/千克)后以及静脉注射地高辛(50微克/千克)后测定心房颤动阈值。在第2组(5只犬)中,药物给药顺序相反。本研究结果如下:1)单独给予地高辛时,对心房颤动阈值无显著影响。2)奎尼丁显著提高了心房颤动阈值(p<0.002),加入地高辛后阈值进一步升高(p<0.002)。3)奎尼丁在右心房部位比在巴赫曼束部位对心房颤动诱发的抑制作用更强,提示奎尼丁对心房纤维有不同作用。

相似文献

1
Independent and interactive effects of digoxin and quinidine on the atrial fibrillation threshold in dogs.地高辛和奎尼丁对犬心房颤动阈值的独立及交互作用
J Am Coll Cardiol. 1985 Jul;6(1):119-23. doi: 10.1016/s0735-1097(85)80262-x.
2
[Pharmacologic restoration of sinus rhythm in atrial flutter and fibrillation].[心房扑动和心房颤动中窦性心律的药物恢复]
Vnitr Lek. 1989 Feb;35(2):145-50.
3
Digoxin -- quinidine interaction.地高辛与奎尼丁的相互作用。
Johns Hopkins Med J. 1979 Dec;145(6):227-9.
4
Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation.维拉帕米 - 奎尼丁与地高辛 - 奎尼丁在急诊科治疗阵发性心房颤动中的疗效比较
Ann Emerg Med. 1997 Jan;29(1):126-34. doi: 10.1016/s0196-0644(97)70318-4.
5
The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation.静脉注射胺碘酮转复慢性心房颤动的疗效。胺碘酮与奎尼丁转复心房颤动的比较。
Arch Intern Med. 1996 Jan 8;156(1):49-53.
6
Effect of quinidine on serum digoxin concentrations.
Am J Hosp Pharm. 1979 Jul;36(7):968-71.
7
Conversion of atrial fibrillation with quinidine sulfate in a dog.硫酸奎尼丁对犬心房颤动的转复作用
J Am Vet Med Assoc. 1967 Sep 1;151(5):582-9.
8
Apparent quinidine-induced digoxin toxicity after withdrawal of pentobarbital: a case of sequential drug interactions.
Arch Intern Med. 1979 Mar;139(3):363-5.
9
[The use of digitalis glycosides in atrial fibrillation].[洋地黄糖苷在心房颤动中的应用]
Z Kardiol. 1994;83 Suppl 5:71-3.
10
Effect of quinidine on digoxin concentration in skeletal muscle and serum in patients with atrial fibrillation. Evidence for reduced binding of digoxin in muscle.
N Engl J Med. 1981 Jul 23;305(4):209-11. doi: 10.1056/NEJM198107233050407.

引用本文的文献

1
Effects of acetyl strophanthidin on duration of atrial fibrillation in the neurally-intact and blockaded dog.
Cardiovasc Drugs Ther. 1988 Nov;2(4):569-77. doi: 10.1007/BF00051197.
2
The relation of quinidine-induced elevation of serum digoxin concentration to the conversion of atrial fibrillation-flutter: a pilot study.
Cardiovasc Drugs Ther. 1989 Dec;3(6):929-30. doi: 10.1007/BF01869583.